Pharmacological profile of dual TxA2 antagonist and Tx synthase inhibitor discussed at ISTH July 10, 2001
Prolonged inhibition of factor Xa with SanOrg-34006 provides high patency rate after thrombolysis July 10, 2001
Factor Xa-selective anticoagulant DPC-423 has oral bioavailability and antithrombotic activity July 10, 2001